This memorandum highlights some annual general meeting (AGM) considerations for UK foreign private issuers (FPIs) with listings in the United States arising from coronavirus (COVID-19), i...
The coronavirus (COVID-19) emergency has led to the debt of many companies in private equity portfolios trading at a significant discount. As a result, an increasing number of private equ...
With the onset of the coronavirus (COVID-19) pandemic, this memorandum provides a brief summary of the first of what will likely be multiple rounds of measures taken, and guidance issued,...
Extreme dislocation and a major sell-off in global equity markets have led to many public companies finding their stock prices at severely depressed levels, often over 50% off last twelve...
Today, the U.S. antitrust agencies continued to take steps to deal with the disruption caused by the coronavirus (COVID-19). Overall, the agencies are taking steps to limit in-person inte...
On March 13, 2020, the Federal Trade Commission (“FTC”) Premerger Notification Office announced that it would adopt an e-filing system for all submissions under the Hart-Scott-Rodino ...
The coronavirus (COVID-19) is having enormous impact on all of us globally. We have been getting a broad array of questions about funding options and liquidity risk management. Our alert ...
U.S. and global stock markets have experienced a significant downturn and increased volatility stemming from the coronavirus (COVID-19), this weekend’s shock in the commodity markets an...
Now is the season when many public companies are planning for and getting ready to finalize, print and mail a proxy statement for the annual meeting. What if, unfortunately, a company nee...
It is obvious that the risks presented by the novel coronavirus (COVID-19) transcend “business as usual” for market participants. How should Boards be approaching the risks and opport...